The IWMF is aware that the potential cost of novel oral medications such as IMBRUVICA® (ibrutinib) is a recent and growing concern to the WM community. The Johnson & Johnson Patient Assistance Foundation provides assistance to uninsured US patients who lack the financial resources to pay for certain medicines, including IMBRUVICA®. To see if you qualify, call the Johnson & Johnson Patient Assistance Foundation at 1-800-652-6227, or visit its website at www.jjpaf.org(link is external).
Patients with limited financial resources taking medications marketed by other pharmaceutical companies are encouraged to contact the financial assistance programs of those respective pharmaceutical companies – in many cases, some form of help is available for those in need. Assistance is also provided by non-profit foundations for WM patients who are insured but need help with drug co-pays. Visit the IWMF website for more information.